Clinical trial

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

NCT05119179

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2021-11-22

PhasePHASE4

Study timeline

Study start (actual)2021-11-22Date precision: day

Registry last updated2026-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

PreDiabetesunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

Sponsors & collaborators

The University of Texas Health Science Center, Houstonlead sponsor

Vanderbilt University Medical Centercollaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05119179 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.